Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival, Ann. Surg, vol.240, pp.644-657, 2004. ,
Chemotherapy permits resection of metastatic colorectal cancer: Experience from Intergroup N9741, Ann. Oncol, vol.16, pp.425-429, 2005. ,
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: The gruppo oncologico nord ovest, J. Clin. Oncol, vol.25, pp.1670-1676, 2007. ,
FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study-Prodige 14-ACCORD 21 (METHEP-2), a unicancer GI trial, J. Clin. Oncol, vol.34, p.3512, 2016. ,
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer, J. Clin. Oncol, vol.26, pp.3213-3221, 2008. ,
Prognostic value of the combination of circulating tumor cells plus kras in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab, Clin. Colorectal Cancer, vol.12, pp.280-286, 2013. ,
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents, Ann. Oncol, vol.21, pp.1006-1012, 2010. ,
Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer, BMC Cancer, vol.15, p.202, 2015. ,
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: The ancillary CirCe 07 study to the LAP 07 trial, Ann. Oncol, vol.24, pp.2057-2061, 2013. ,
Disseminated and circulating tumor cells in gastrointestinal oncology, Crit. Rev. Oncol. Hematol, vol.82, pp.103-115, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00711407
Going with the flow: From circulating tumor cells to DNA, Sci. Transl. Med, 2013. ,
Gefitinib treatment in EGFR mutated caucasian NSCLC: Circulating-free tumor dna as a surrogate for determination of egfr status, J. Thorac. Oncol, vol.9, pp.1345-1353, 2014. ,
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA, Nat. Med, vol.20, pp.430-435, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02168071
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients, Nat. Med, vol.795, 2015. ,
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: A retrospective, exploratory analysis of the CORRECT trial, Lancet Oncol, vol.16, pp.937-948, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02326053
Transient disappearance of RAS mutant clones in plasma: A counterintuitive clinical use of EGFR inhibitors in RAS mutant metastatic colorectal cancer, Cancers, vol.11, p.42, 2019. ,
Circulating mutant DNA to assess tumor dynamics, Nat. Med, vol.14, pp.985-990, 2008. ,
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer, Ann. Oncol, vol.26, pp.1715-1722, 2015. ,
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage, II colon cancer. Sci. Transl. Med, vol.8, 2016. ,
A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial, Ann. Surg. Oncol, vol.20, pp.4289-4297, 2013. ,
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases, Clin. Cancer Res, vol.10, pp.6897-6904, 2004. ,
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types, Mol. Oncol, vol.9, pp.783-790, 2015. ,
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients: ctDNA and CTC in metastatic triple negative breast cancer, Int. J. Cancer, vol.136, pp.2158-2165, 2015. ,
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: The AGEO RASANC prospective multicenter study, Ann. Oncol, vol.29, pp.1211-1219, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02332812
Base-position error rate analysis of next-generation sequencing applied to circulating tumor dna in non-small cell lung cancer: A prospective study, PLoS Med, vol.13, p.1002199, 2016. ,
Detection of circulating tumor dna in early-and late-stage human malignancies, Sci. Transl. Med, 2014. ,
Peripheral circulating tumor dna detection predicts poor outcomes after liver resection for metastatic colorectal cancer, Ann. Surg. Oncol, vol.26, pp.1824-1832, 2019. ,
Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC), J. Clin. Oncol, vol.36, p.3516, 2018. ,
Early evaluation of circulating tumor dna as marker of therapeutic efficacy in metastatic colorectal cancer patients (PLACOL Study), Clin. Cancer Res, vol.23, pp.5416-5425, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02353169
Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients, Clin. Chem, vol.59, pp.1722-1731, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02332865
Multiple hotspot mutations scanning by single droplet digital PCR, Clin. Chem, vol.64, pp.317-328, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01823628
A Study of hypermethylated circulating tumor DNA as a universal colorectal cancer biomarker, Clin. Chem, vol.62, pp.1129-1139, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02295782
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma: Circulating tumor DNA in uveal melanoma, Int. J. Cancer, vol.134, pp.1207-1213, 2014. ,
Circulating tumor cell technologies, Mol. Oncol, vol.10, pp.374-394, 2016. ,
Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays, Proc. Natl. Acad. Sci, vol.107, pp.14524-14529, 2010. ,
Lessons learned: Transfer of the high-definition circulating tumor cell assay platform to development as a commercialized clinical assay platform, Clin. Pharmacol. Ther, vol.102, pp.777-785, 2017. ,
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap): Toward a real liquid biopsy in metastatic breast and prostate cancer, Int. J. Cancer, vol.143, pp.2584-2591, 2018. ,
Prognostic significance of serum free amino acids in head and neck cancers, Cells, vol.8, p.428, 2019. ,
Tumor extracellular matrix remodeling: new perspectives as a circulating tool in the diagnosis and prognosis of solid tumors, vol.8, p.81, 2019. ,